|
1
|
Zhang H, Liu C, Tan Z and Zhang T:
Segmentectomy versus Wedge resection for stage I non-small cell
lung cancer: A Meta-analysis. J Surg Res. 243:371–379. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu H, Yin Q, Yang G and Qie P: Including
3564 patients prognostic impact of tumor spread through air spaces
in non-small cell lung cancers: A meta-analysis. Pathol Oncol Res.
2019.(Epub ahead of print).
|
|
3
|
Im Y, Park HY, Shin S, Shin SH, Lee H, Ahn
JH, Sohn I, Cho JH, Kim HK, Zo JI, et al: Prevalence of and risk
factors for pulmonary complications after curative resection in
otherwise healthy elderly patients with early stage lung cancer.
Respir Res. 20:1362019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hung JJ, Jeng WJ, Hsu WH, Chou TY, Huang
BS and Wu YC: Predictors of death, local recurrence, and distant
metastasis in completely resected pathological stage-I
non-small-cell lung cancer. J Thorac Oncol. 7:1115–1123. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng B, Zhang J, Woods JS and Peng W:
Molecular markers and pathogenically targeted therapy in non-small
cell lung cancer. Front Med China. 3:245–255. 2009. View Article : Google Scholar
|
|
6
|
Stewart DJ: Wnt signaling pathway in
non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shang S, Hua F and Hu ZW: The regulation
of β-catenin activity and function in cancer: Therapeutic
opportunities. Oncotarget. 8:33972–33989. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu X, Sun PL, Li JZ, Jheon S, Lee CT and
Chung JH: Aberrant Wnt1/β-catenin expression is an independent poor
prognostic marker of non-small cell lung cancer after surgery. J
Thorac Oncol. 6:716–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Paul S and Dey A: Wnt signaling and cancer
development: Therapeutic implication. Neoplasma. 55:165–176.
2008.PubMed/NCBI
|
|
10
|
Chen W, Huang Y, Zhang S, Zheng X, Xie S,
Mao J, Cai Y, Lu X, Hu L, Shen J, et al: MicroRNA-212 suppresses
nonsmall lung cancer invasion and migration by regulating
ubiquitin-specific protease-9. J Cell Biochem. 120:6482–6489. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang C, Bi C, Jiang X, Tian T, Huang X,
Wang C, Fernandez MR, Iqbal J, Chan WC, McKeithan TW, et al: The
miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by
targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway.
Br J Haematol. 185:616–620. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li JP, Liao XH, Xiang Y, Yao A, Song RH,
Zhang ZJ, Huang F, Dai ZT and Zhang TC: Hyperoside and let-7a-5p
synergistically inhibits lung cancer cell proliferation via
inducing G1/S phase arrest. Gene. 679:232–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Loo JM, Scherl A, Nguyen A, Man FY,
Weinberg E, Zeng Z, Saltz L, Paty PB and Tavazoie SF: Extracellular
metabolic energetics can promote cancer progression. Cell.
160:393–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
John K, Wu J, Lee BW and Farah CS:
MicroRNAs in head and neck cancer. Int J Dent. 2013:6502182013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dinami R, Buemi V, Sestito R, Zappone A,
Ciani Y, Mano M, Petti E, Sacconi A, Blandino G, Giacca M, et al:
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent
apoptosis protection and telomere maintenance in basal-type breast
cancer cells. Oncotarget. 8:95674–95691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chu K, Gao G, Yang X, Ren S, Li Y, Wu H,
Huang Y and Zhou C: miR-512-5p induces apoptosis and inhibits
glycolysis by targeting p21 in non-small cell lung cancer cells.
Int J Oncol. 48:577–586. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J, Lei H, Xu Y and Tao ZZ: miR-512-5p
suppresses tumor growth by targeting hTERT in telomerase positive
head and neck squamous cell carcinoma in vitro and in vivo. PLoS
One. 10:e01352652015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Niu X, Liu S, Jia L and Chen J: Role of
miR-3619-5p in β-catenin-mediated non-small cell lung cancer growth
and invasion. Cell Physiol Biochem. 37:1527–1536. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu H, Lin D, Wang L, Liu N and Wang E:
Expression and mutation of β-catenin in non-small cell lung cancer.
Zhongguo Fei Ai Za Zhi. 7:409–413. 2004.(In Chinese). PubMed/NCBI
|
|
22
|
Vargas DA, Sun M, Sadykov K, Kukuruzinska
MA and Zaman MH: The integrated role of Wnt/β-catenin,
N-glycosylation, and E-cadherin-mediated adhesion in network
dynamics. PLoS Comput Biol. 12:e10050072016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie C, Jiang G, Fan C, Zhang X, Zhang Y,
Miao Y, Lin X, Wu J, Wang L, Liu Y, et al: ARMC8α promotes
proliferation and invasion of non-small cell lung cancer cells by
activating the canonical Wnt signaling pathway. Tumour Biol.
35:8903–8911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schneikert J and Behrens J: The canonical
Wnt signalling pathway and its APC partner in colon cancer
development. Gut. 56:417–425. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shu Z, Chen L and Ding D: miR-582-5P
induces colorectal cancer cell proliferation by targeting
adenomatous polyposis coli. World J Surg Oncol. 14:2392016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li M, Tian L, Wang L, Yao H, Zhang J, Lu
J, Sun Y, Gao X, Xiao H and Liu M: Down-regulation of miR-129-5p
inhibits growth and induces apoptosis in laryngeal squamous cell
carcinoma by targeting APC. PLoS One. 8:e778292013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang S, Dong Y, Zhang Y, Wang X, Xu L,
Yang S, Li X, Dong H, Xu L, Su L, et al: DACT2 is a functional
tumor suppressor through inhibiting Wnt/β-catenin pathway and
associated with poor survival in colon cancer. Oncogene.
34:2575–2585. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang Y, Yang JJ, Tao H and Jin WS: New
perspectives on β-catenin control of cell fate and proliferation in
colon cancer. Food Chem Toxicol. 740:14–19. 2014. View Article : Google Scholar
|
